24th May 2021 10:28
Ap24
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING INA CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader | J.P. Morgan Securities Plc |
Company dealt in | UDG Healthcare Plc |
Class of relevant security to which the dealings being disclosed relate (Note 1) | €0.05 ordinary shares |
Date of dealing | 21 May 2021 |
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
420,179 | 10.4600 GBP | 10.2200 GBP |
Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
989,376 | 10.4602 GBP | 10.2200 GBP |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) |
Equity Swap | Decrease Long
Decrease Short
Increase Long
Increase Short
Opening a Long Position | 3,606 4,555 3,727 1,378 474 978 742 5,411 3,820 3,905 852 826 44,577 841
1,459 11,191 14,140 50,000 1,276 536,686 10 1,400
368 223 147 1,064 77 11,376 5 7,140 413 558 466 555 74 833 280 9 10,163 37,453
8,033 719 72,485 5,069 1,089 5,000 21,940
75,000 | 10.2301 GBP 10.2325 GBP 10.2381 GBP 10.2403 GBP 10.2406 GBP 10.2601 GBP 10.2649 GBP 10.2917 GBP 10.3593 GBP 10.4124 GBP 10.4503 GBP 10.4506 GBP 10.4541 GBP 10.4600 GBP
10.2198 GBP 10.2514 GBP 10.3987 GBP 10.4140 GBP 10.4250 GBP 10.4257 GBP 10.4595 GBP 10.4598 GBP
10.2299 GBP 10.2399 GBP 10.3200 GBP 10.3210 GBP 10.3347 GBP 10.3756 GBP 10.4100 GBP 10.4108 GBP 10.4130 GBP 10.4157 GBP 10.4260 GBP 10.4264 GBP 10.4294 GBP 10.4349 GBP 10.4394 GBP 10.4395 GBP 10.4595 GBP 10.4600 GBP
10.2210 GBP 10.2315 GBP 10.2361 GBP 10.3284 GBP 10.4007 GBP 10.4052 GBP 10.4512 GBP
10.4222 GBP |
Ap25
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3) |
|
|
|
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securitiesunder any option referred to on this form or relating to the voting rights or future acquisitionor disposal of any relevant securities to which any derivative referred to on this form is referenced.If none, this should be stated.
Date of disclosure | 24 May 2021 |
Contact name | Alwyn Basch |
Telephone number | 020 7742 7407 |
Name of offeree/offeror with which connected | UDG Healthcare Plc |
Nature of connection (Note 6) | Financial adviser to CD&R Fund XI |
Related Shares:
UDG.L